ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

Labcorp has announced the availability of ColoSense, its ribonucleic acid (RNA)-based at-home screening test for colorectal cancer that has been approved by the US Food and Drug Administration (FDA).

About four years ago, Stephanie Servetas, a microbiologist at the National Institute of Standards and Technology (NIST), and her colleagues set out on a unique quest: They planned to mail a poop ...

Have you ever tried a popular test kit because you wanted to know about your own gut microbiome? In fact, a study reported that when stool samples from the same person were sent to multiple testing ...

Like Cologuard, which the FDA approved in 2014, ColoSense is a stool-based screening test for colorectal cancer. Cologuard detects abnormal DNA and blood, while ColoSense tests for RNA markers and ...

If you boil hot dogs in Gatorade, will it really make them blue? Yes. Does that mean you should do it? That is up to you and ...

Steffini Stalos, DO, is board-certified in pathology and lab medicine. She is currently Chief Medical Officer of Blood Associates, a lab consultancy firm. Cologuard is an at-home test for detecting ...

Send identical stool to seven different gut microbiome test companies and you will get seven wildly different answers. That is essentially what a new study did, and the results should give anyone who ...

Whether you’re managing chronic allergies or just curious about your body’s inner workings, it’s common to want to know everything you can about your health. And at-home tests offer a convenient ...